Long-term results from the IDEAL-CRT phase 1/2 trial of isotoxically dose-escalated radiation therapy and concurrent chemotherapy for stage II/III non-small cell lung cancer
Fenwick, J.D., Landau, D.B., Baker, A., Bates, A.T., Eswar, C., Garcia-Alonso, A., Harden, S.V., Illsley, M.C., Laurence, V., Malik, Z., Mayles, W.P.M., Miles, E., Mohammed, N., Spicer, J., Wells, P.,Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2019.11.397
Date:
December, 2019
File:
PDF, 1.48 MB
2019
File converter
More search results
More benefits 
